Clinical trial
Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.
NCT00466895 · Leslie Andritsos, Other · Completed
Key facts
| NCT number | NCT00466895 |
|---|---|
| Title | Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia. |
| Official title | Phase I Study of Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia. |
| Lead sponsor | Leslie Andritsos, Other |
| Collaborators | Celgene Corporation Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | lenalidomide |
| Enrollment | 37 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2014 |
| Completion | Jul 1, 2016 |
| First posted | Apr 27, 2007 |
| Last update posted | Nov 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: